Client MOMA Therapeutics Establishes Bayer Collaboration, License Agreement in Oncology
October 10, 2024
October 10, 2024
BOSTON, Massachusetts, Oct. 10 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised MOMA Therapeutics in a collaboration and exclusive license agreement with Bayer to develop and commercialize a small molecule oncology program based on MOMA's proprietary KNOMATIC platform. The collaboration was announced on October 8.
Under the agreement, Bayer will be responsible for completing further preclinical, development and commercial activities.
Ropes & Gray advised MOMA Therapeutics in a collaboration and exclusive license agreement with Bayer to develop and commercialize a small molecule oncology program based on MOMA's proprietary KNOMATIC platform. The collaboration was announced on October 8.
Under the agreement, Bayer will be responsible for completing further preclinical, development and commercial activities.